Osteoblastic molecular scaffold Gab1 is required for maintaining bone homeostasis

Journal of Cell Science

Volumn 123, Issue 5, 2010, Pages 682-689

  Weng, Tujun ^a   Mao, Fengfeng ^a   Wang, Youliang ^a   Sun, Qiang ^a   Li, Ruixin ^b   Yang, Guan ^a   Zhang, Xizheng ^b   Luo, Jincai ^c   Feng, Gen Sheng ^d   Yang, Xiao ^a,e  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b Tianjin Institute of Medical Equipment   (China)

^c PEKING UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

AKT; Apoptosis; Bone mass; ERK; Gab1; Osteoblast

Indexed keywords

INSULIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN KINASE B; SCAFFOLD PROTEIN; SCAFFOLD PROTEIN GAB1; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE; BONE DEVELOPMENT; BONE MASS; BONE MINERALIZATION; BONE REMODELING; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRABECULAR BONE;

ANIMALS; APOPTOSIS; BIOMECHANICS; BLOTTING, WESTERN; BONE AND BONES; BONE DENSITY; BONE RESORPTION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU HYBRIDIZATION; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOGENESIS; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; RANK LIGAND; RNA INTERFERENCE; TOMOGRAPHY, X-RAY COMPUTED;

MUS;

EID: 77149124277     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.058396     Document Type: Article

References (53)

1. Bard-Chapeau, E. A., Hevener, A. L., Long, S., Zhang, E. E., Olefsky, J. M. and Feng, G. S. (2005). Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action. Nat. Med. 11, 567-571.
2. Bentires-Alj, M., Gil, S. G., Chan, R., Wang, Z. C., Wang, Y., Imanaka, N., Harris, L. N., Richardson, A., Neel, B. G. and Gu, H. (2006). A role for the scaffolding adapter GAB2 in breast cancer. Nat. Med. 12, 114-121.
3. Boyce, B. F., Xing, L. and Chen, D. (2005). Osteoprotegerin, the bone protector, is a surprising target for beta-catenin signaling. Cell Metab. 2, 344-345.
4. Cai, T., Nishida, K., Hirano, T. and Khavari, P. A. (2002). Gab1 and SHP-2 promote Ras/MAPK regulation of epidermal growth and differentiation. J. Cell Biol. 159, 103-112.
5. Canalis, E. (1983). Effect of hormones and growth factors on alkaline phosphatase activity and collagen synthesis in cultured rat calvariae. Metabolism 32, 14-20.
6. Cunnick, J. M., Dorsey, J. F., Munoz-Antonia, T., Mei, L. and Wu, J. (2000). Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor. J. Biol. Chem. 275, 13842-13848.
7. Fujita, T., Azuma, Y., Fukuyama, R., Hattori, Y., Yoshida, C., Koida, M., Ogita, K. and Komori, T. (2004). Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J. Cell Biol. 166, 85-95.
8. Fulzele, K., DiGirolamo, D. J., Liu, Z., Xu, J., Messina, J. L. and Clemens, T. L. (2007). Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J. Biol. Chem. 282, 25649-25658.
9. Ge, C., Xiao, G., Jiang, D. and Franceschi, R. T. (2007). Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J. Cell Biol. 176, 709-718.
10. Glass, D. A., 2nd, Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A. et al. (2005). Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8, 751-764.
11. Gu, H. and Neel, B. G. (2003). The "Gab" in signal transduction. Trends Cell Biol. 13, 122-130.
12. Gu, H., Saito, K., Klaman, L. D., Shen, J., Fleming, T., Wang, Y., Pratt, J. C., Lin, G., Lim, B., Kinet, J. P. et al. (2001). Essential role for Gab2 in the allergic response. Nature 412, 186-190.
13. Hofbauer, L. C., Dunstan, C. R., Spelsberg, T. C., Riggs, B. L. and Khosla, S. (1998). Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem. Biophys. Res. Commun. 250, 776-781.
14. Holgado-Madruga, M., Emlet, D. R., Moscatello, D. K., Godwin, A. K. and Wong, A. J. (1996). A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379, 560-564.
15. Holgado-Madruga, M., Moscatello, D. K., Emlet, D. R., Dieterich, R. and Wong, A. J. (1997). Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proc. Natl. Acad. Sci. USA 94, 12419-12424.
16. Holmen, S. L., Zylstra, C. R., Mukherjee, A., Sigler, R. E., Faugere, M. C., Bouxsein, M. L., Deng, L., Clemens, T. L. and Williams, B. O. (2005). Essential role of betacatenin in postnatal bone acquisition. J. Biol. Chem. 280, 21162-21168.
17. Ingham, R. J., Santos, L., Dang-Lawson, M., Holgado-Madruga, M., Dudek, P., Maroun, C. R., Wong, A. J., Matsuuchi, L. and Gold, M. R. (2001). The Gab1 docking protein links the b cell antigen receptor to the phosphatidylinositol 3-kinase/Akt signaling pathway and to the SHP2 tyrosine phosphatase. J. Biol. Chem. 276, 12257-12265.
18. Itoh, M., Yoshida, Y., Nishida, K., Narimatsu, M., Hibi, M. and Hirano, T. (2000). Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokineinduced extracellular signal-regulated kinase mitogen-activated protein kinase activation. Mol. Cell. Biol. 20, 3695-3704.
19. Itoh, S., Yoshitake, F., Narita, H., Ishihara, K. and Ebisu, S. (2007). Gab2 plays distinct roles in bone homeostasis at different time points. J. Bone Miner. Metab. 25, 81-85.
20. Jochum, W., David, J. P., Elliott, C., Wutz, A., Plenk, H., Jr, Matsuo, K. and Wagner, E. F. (2000). Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat. Med. 6, 980-984.
21. Karsenty, G. and Wagner, E. F. (2002). Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389-406.
22. Kawamura, N., Kugimiya, F., Oshima, Y., Ohba, S., Ikeda, T., Saito, T., Shinoda, Y., Kawasaki, Y., Ogata, N., Hoshi, K. et al. (2007). Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS ONE 2, e1058.
23. Kearns, A. E., Khosla, S. and Kostenuik, P. J. (2008). Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr. Rev. 29, 155-192.
24. Korhonen, J. M., Said, F. A., Wong, A. J. and Kaplan, D. R. (1999). Gab1 mediates neurite outgrowth, DNA synthesis, and survival in PC12 cells. J. Biol. Chem. 274, 37307-37314.
25. Koyama, T., Nakaoka, Y., Fujio, Y., Hirota, H., Nishida, K., Sugiyama, S., Okamoto, K., Yamauchi-Takihara, K., Yoshimura, M., Mochizuki, S. et al. (2008). Interaction of scaffolding adaptor protein Gab1 with tyrosine phosphatase SHP2 negatively regulates IGF-I-dependent myogenic differentiation via the ERK1/2 signaling pathway. J. Biol. Chem. 283, 24234-24244.
26. Kream, B. E., Smith, M. D., Canalis, E. and Raisz, L. G. (1985). Characterization of the effect of insulin on collagen synthesis in fetal rat bone. Endocrinology 116, 296-302.
27. Liang, M., Russell, G. and Hulley, P. A. (2008). Bim, Bak, and Bax regulate osteoblast survival. J. Bone Miner. Res. 23, 610-620.
28. Liu, X., Bruxvoort, K. J., Zylstra, C. R., Liu, J., Cichowski, R., Faugere, M. C., Bouxsein, M. L., Wan, C., Williams, B. O. and Clemens, T. L. (2007). Lifelong accumulation of bone in mice lacking Pten in osteoblasts. Proc. Natl. Acad. Sci. USA 104, 2259-2264.
29. Liu, Y. and Rohrschneider, L. R. (2002). The gift of Gab. FEBS Lett. 515, 1-7.
30. Mak, K. K., Bi, Y., Wan, C., Chuang, P. T., Clemens, T., Young, M. and Yang, Y. (2008). Hedgehog signaling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression. Dev. Cell 14, 674-688.
31. Murakami, T., Matoba, H., Kuga, Y., Ozawa, S., Kubota, K. and Yoshida, S. (1998). Hyponatremia in a patient with chronic inflammatory disease. Intern. Med. 37, 792-795.
32. Nakaoka, Y., Nishida, K., Narimatsu, M., Kamiya, A., Minami, T., Sawa, H., Okawa, K., Fujio, Y., Koyama, T., Maeda, M. et al. (2007). Gab family proteins are essential for postnatal maintenance of cardiac function via neuregulin-1/ErbB signaling. J. Clin. Invest. 117, 1771-1781.
33. Nishida, K. and Hirano, T. (2003). The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors. Cancer Sci. 94, 1029-1033.
34. Nishida, K., Wang, L., Morii, E., Park, S. J., Narimatsu, M., Itoh, S., Yamasaki, S., Fujishima, M., Ishihara, K., Hibi, M. et al. (2002). Requirement of Gab2 for mast cell development and KitL/c-Kit signaling. Blood 99, 1866-1869.
35. Ogata, N., Chikazu, D., Kubota, N., Terauchi, Y., Tobe, K., Azuma, Y., Ohta, T., Kadowaki, T., Nakamura, K. and Kawaguchi, H. (2000). Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J. Clin. Invest. 105, 935-943.
36. Okamoto, M., Murai, J., Yoshikawa, H. and Tsumaki, N. (2006). Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J. Bone Miner. Res. 21, 1022-1033.
37. Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M. and Recker, R. R. (1987). Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595-610.
38. Rosen, D. M. and Luben, R. A. (1983). Multiple hormonal mechanisms for the control of collagen synthesis in an osteoblast-like cell line, MMB-1. Endocrinology 112, 992-999.
39. Sachs, M., Brohmann, H., Zechner, D., Muller, T., Hulsken, J., Walther, I., Schaeper, U., Birchmeier, C. and Birchmeier, W. (2000). Essential role of Gab1 for signaling by the c-Met receptor in vivo. J. Cell Biol. 150, 1375-1384.
40. Scheid, M. P. and Woodgett, J. R. (2001). PKB/AKT: functional insights from genetic models. Nat. Rev. Mol. Cell. Biol. 2, 760-768.
41. Stein, G. S. and Lian, J. B. (1993). Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr. Rev. 14, 424-442.
42. Sun, Q., Zhang, Y., Yang, G., Chen, X., Zhang, Y., Cao, G., Wang, J., Sun, Y., Zhang, P., Fan, M. et al. (2008). Transforming growth factor-beta-regulated miR-24 promotes skeletal muscle differentiation. Nucleic Acids Res. 36, 2690-2699.
43. Takahashi-Tezuka, M., Yoshida, Y., Fukada, T., Ohtani, T., Yamanaka, Y., Nishida, K., Nakajima, K., Hibi, M. and Hirano, T. (1998). Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol. Cell. Biol. 18, 4109-4117.
44. Tan, X., Weng, T., Zhang, J., Wang, J., Li, W., Wan, H., Lan, Y., Cheng, X., Hou, N., Liu, H. et al. (2007). Smad4 is required for maintaining normal murine postnatal bone homeostasis. J. Cell Sci. 120, 2162-2170.
45. Thomas, D. M., Hards, D. K., Rogers, S. D., Ng, K. W. and Best, J. D. (1996). Insulin receptor expression in bone. J. Bone Miner. Res. 11, 1312-1320.
46. Thrailkill, K. M., Lumpkin, C. K., Jr, Bunn, R. C., Kemp, S. F. and Fowlkes, J. L. (2005). Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am. J. Physiol. Endocrinol. Metab. 289, E735-E745.
47. Wada, T., Nakashima, T., Oliveira-dos-Santos, A. J., Gasser, J., Hara, H., Schett, G. and Penninger, J. M. (2005). The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis. Nat. Med. 11, 394-399.
48. Winnay, J. N., Bruning, J. C., Burks, D. J. and Kahn, C. R. (2000). Gab-1-mediated IGF-1 signaling in IRS-1-deficient 3T3 fibroblasts. J. Biol. Chem. 275, 10545-10550.
49. Yamasaki, S., Nishida, K., Yoshida, Y., Itoh, M., Hibi, M. and Hirano, T. (2003). Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2. Oncogene 22, 1546-1556.
50. Yang, G., Sun, Q., Teng, Y., Li, F., Weng, T. and Yang, X. (2008). PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1alpha signaling and endoplasmic reticulum stress. Development 135, 3587-3597.
51. Yang, W., Klaman, L. D., Chen, B., Araki, T., Harada, H., Thomas, S. M., George, E. L. and Neel, B. G. (2006). An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev. Cell 10, 317-327.
52. Zha, L., Hou, N., Wang, J., Yang, G., Gao, Y., Chen, L. and Yang, X. (2008). Collagen1alpha1 promoter drives the expression of Cre recombinase in osteoblasts of transgenic mice. J. Genet. Genomics 35, 525-530.
53. Zhang, M., Xuan, S., Bouxsein, M. L., von Stechow, D., Akeno, N., Faugere, M. C., Malluche, H., Zhao, G., Rosen, C. J., Efstratiadis, A. et al. (2002). Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J. Biol. Chem. 277, 44005-44012